Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt